Soleus Capital Management »

Satellos Bioscience shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Satellos Bioscience shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Satellos Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Satellos Bioscience held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Satellos Bioscience by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.3M 414k 5.63

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Celcuity (CELC)
Tg Therapeutics (TGTX)
Insulet Corporation (PODD)
Novocure Ord Shs (NVCR)
United Therapeutics Corporation (UTHR)
Praxis Precision Medicines I Com New (PRAX)
Vericel (VCEL)
Alkermes SHS (ALKS)
Biosante Pharmaceuticals (ANIP)
Globus Med Cl A (GMED)
Geron Corporation (GERN)
Twist Bioscience Corp (TWST)
Edgewise Therapeutics (EWTX)
Beta Bionics (BBNX)

View all positions for Soleus Capital Management

Top funds holding Satellos Bioscience

Franklin Resources
Vivo Capital
Point72 Asset Management
Woodline Partners
Sphera Funds Management
Suvretta Capital Management
Soleus Capital Management
Avidity Partners Management
Millennium Management
683 Capital Management
Empery Asset Management
ADAR1 Capital Management
Citadel Advisors
Hrt Financial
Morgan Stanley

View all funds holding Satellos Bioscience